Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience
MIEVIS, Carole ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Jansen, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Duysinx, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
Cousin, François ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
LOUIS, Thomas ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
BAIWIR, Manon ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
ERNST, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
WONNER, Michel ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Hustinx, Roland ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Lovinfosse, Pierre ✱; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Coucke, Philippe ✱; Université de Liège - ULiège > Département des sciences cliniques > Radiothérapie
✱ These authors have contributed equally to this work.
Language :
English
Title :
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience
Nagata, Y., Hiraoka, M., Shibata, T., Onishi, H., Kokubo, M., Karasawa, K., et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 93 (2015), 989–996.
Guckenberger, M., Allgäuer, M., Appold, S., Dieckmann, K., Ernst, I., Ganswindt, U., et al. Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8 (2013), 1050–1058.
Ricardi, U., Frezza, G., Filippi, A.R., Badellino, S., Levis, M., Navarria, P., et al. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study. Lung Cancer 84 (2014), 248–253.
de Ruiter, J.C., Heineman, D.J., Daniels, J.M., van Diessen, J.N., Damhuis, R.A., Hartemink, K.J., The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands. Lung Cancer 144 (2020), 64–70.
Haque, W., Szeja, S., Tann, A., Kalra, S., Teh, B.S., Changes in treatment patterns and overall survival in patients with early-stage non-small cell lung cancer in the United States after the incorporation of stereotactic ablative radiation therapy: A population-based analysis. Am J Clin Oncol 41 (2018), 259–266.
Dalwadi, S.M., Szeja, S.S., Bernicker, E.H., Butler, E.B., Teh, B.S., Farach, A.M., Practice patterns and outcomes in elderly stage I non-small-cell lung cancer: A 2004 to 2012 SEER analysis. Clin Lung Cancer 19 (2018), e269–e276.
Lee, P., Loo, B.W., Biswas, T., Ding, G.X., El Naqa, I.M., Jackson, A., et al. Local control after stereotactic body radiation therapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 110 (2021), 160–171.
Nagata, Y., Hiraoka, M., Mizowaki, T., Narita, Y., Matsuo, Y., Norihisa, Y., et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys 75 (2009), 343–347.
Guckenberger, M., Andratschke, N., Dieckmann, K., Hoogeman, M.S., Hoyer, M., Hurkmans, C., et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124 (2017), 11–17.
Timmerman, R.D., Paulus, R., Pass, H.I., Gore, E.M., Edelman, M.J., Galvin, J., et al. Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial. JAMA Oncol 4 (2018), 1263–1266.
Timmerman, R., Paulus, R., Galvin, J., Michalski, J., Straube, W., Bradley, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303 (2010), 1070–1076.
Bezjak, A., Paulus, R., Gaspar, L.E., Timmerman, R.D., Straube, W.L., Ryan, W.F., et al. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol 37 (2019), 1316–1325.
Iwata, H., Ishikura, S., Murai, T., Iwabuchi, M., Inoue, M., Tatewaki, K., et al. A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors. Int J Clin Oncol 22 (2017), 706–714.
Diez, P., Hanna, G.G., Aitken, K.L., van As, N., Carver, A., Colaco, R.J., et al. UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol (r Coll Radiol) 34 (2022), 288–300.
Schwartz, L.H., Litière, S., de Vries, E., Ford, R., Gwyther, S., Mandrekar, S., et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer 62 (2016), 132–137.
Huang, K., Palma, D.A., IASLC Advanced Radiation Technology Committee. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist. J Thorac Oncol 10 (2015), 412–419.
Schemper, M., Smith, T.L., A note on quantifying follow-up in studies of failure time. Control Clin Trials 17 (1996), 343–346.
Eriguchi, T., Takeda, A., Nemoto, T., Tsurugai, Y., Sanuki, N., Tateishi, Y., et al. Relationship between dose prescription methods and local control rate in stereotactic body radiotherapy for early stage non-small-cell lung cancer: systematic review and meta-analysis. Cancers (Basel), 14, 2022, 3815.
Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., Gomi, K., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:7 Suppl 3 (2007), S94–S100.
Zhang, J., Yang, F., Li, B., Li, H., Liu, J., Huang, W., et al. Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis. Int J Radiat Oncol Biol Phys 81 (2011), e305–e316.
Klement, R.J., Sonke, J.-J., Allgäuer, M., Andratschke, N., Appold, S., Belderbos, J., et al. Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments. Int J Radiat Oncol Biol Phys 107 (2020), 579–586.
Tateishi, Y., Takeda, A., Horita, N., Tsurugai, Y., Eriguchi, T., Kibe, Y., et al. Stereotactic body radiation therapy with a high maximum dose improves local control, cancer-specific death, and overall survival in peripheral early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 111 (2021), 143–151.
Inagaki, T., Doi, H., Ishida, N., Ri, A., Tatsuno, S., Wada, Y., et al. Escalated maximum dose in the planning target volume improves local control in stereotactic body radiation therapy for T1-2 lung cancer. Cancers (Basel), 14, 2022, 933.
Janvary, Z.L., Jansen, N., Baart, V., Devillers, M., Dechambre, D., Lenaerts, E., et al. Clinical outcomes of 130 patients with primary and secondary lung tumors treated with cyberknife robotic stereotactic body radiotherapy. Radiol Oncol 51 (2017), 178–186.
Paul, S., Isaacs, A.J., Treasure, T., Altorki, N.K., Sedrakyan, A., Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database. BMJ, 349, 2014, g5575.
Hansen, O., Kristiansen, C., Nielsen, M., Schytte, T., Starup, J.S., Survival after stereotactic radiotherapy in patients with early-stage non-small cell lung cancer. Acta Oncol 58 (2019), 1399–1403.
Grills, I.S., Hope, A.J., Guckenberger, M., Kestin, L.L., Werner-Wasik, M., Yan, D., et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 7 (2012), 1382–1393.
Duvergé, L., Bondiau, P.-Y., Claude, L., Supiot, S., Vaugier, L., Thillays, F., et al. Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer. Lung Cancer 157 (2021), 100–108.
Menoux, I., Antoni, D., Truntzer, P., Keller, A., Massard, G., Noël, G., Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome. Lung Cancer 126 (2018), 201–207.
Lovinfosse, P., Janvary, Z.L., Coucke, P., Jodogne, S., Bernard, C., Hatt, M., et al. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. Eur J Nucl Med Mol Imaging 43 (2016), 1453–1460.
Guiot, J., Vaidyanathan, A., Deprez, L., Zerka, F., Danthine, D., Frix, A.-N., et al. A review in radiomics: Making personalized medicine a reality via routine imaging. Med Res Rev 42 (2022), 426–440.
Wu, V.W.C., Tam, K., Tong, S., Evaluation of the influence of tumor location and size on the difference of dose calculation between Ray Tracing algorithm and Fast Monte Carlo algorithm in stereotactic body radiotherapy of non-small cell lung cancer using CyberKnife. J Appl Clin Med Phys 14 (2013), 68–78.
Dechambre, D., Janvary, L.Z., Jansen, N., Berkovic, P., Mievis, C., Baart, V., et al. Prediction of GTV median dose differences eases Monte Carlo re-prescription in lung SBRT. Phys Med 45 (2018), 88–92.
Boellaard, R., O'Doherty, M.J., Weber, W.A., Mottaghy, F.M., Lonsdale, M.N., Stroobants, S.G., et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37 (2010), 181–200.
